The aim of the present study was to assess the efficacy of psychoeducation as compared with cognitive behavioral group therapy in adults with attention deficit hyperactivity disorder (ADHD) who still had significant symptoms and were in pharmacological treatment. This is the first study on psychoeducation in adults with ADHD. Thirty-two individuals were randomized to two treatment conditions: 15 were in the psychoeducation group and 11 were in the cognitive behavioral group therapy. A total of 30 completed treatment, and 26 completed the follow-up assessments. The results indicated that both treatments were associated with statistically significant improvements on inattention, hyperactivity, impulsivity, and self-esteem. The patients in both groups showed a decrease in anxiety symptoms and obtained significantly lower scores in depression. Measures on functional impairment showed statistically significant differences on improved quality of life and on lower global severity as perceived in self-report and assessed by clinician report. Psychoeducation demonstrated to be an effective treatment in reducing ADHD core symptoms.
Background Dupuytren’s disease leads to progressive finger contractures, limiting hand function. Traditional treatment consists of open partial fasciectomy, which requires hospitalisation, anaesthesia and physiotherapy. Recent introduction of Clostridium hystoliticum collagenase into treatment has minimised the economic impact. Purpose To evaluate the efficacy, safety and financial impact of collagenase versus fasciectomy after its introduction in the hospital. Materials and methods A retrospective observational study was performed in a 400-bed university hospital. All patients treated with collagenase since May 2012 were enrolled in the study. Data were collected from medical histories to study efficacy and safety: sex, age, concomitant disease, pharmacotherapeutic history, previous operations and adverse events. We considered treatment was effective when residual contracture was <5º after 4 weeks of collagenase injection. Costs of surgery and consultation were obtained from the GECLIF (Financial Clinical Management) application. The cost of collagenase was calculated based on the average price of its acquisition by the pharmacy. The average cost of fasciectomy includes costs of surgery, hospital stay and associated consultations. Average cost of treatment with collagenase includes the cost of the drug and associated consultations. We compared average costs between the two treatments using the T-Student-Fisher Test. Confidence intervals were calculated for a confidence level of 95% (CI95%) and p values ≤0.05 were considered statistically significant. Results Nine subjects (7 men and 2 women) with an average age of 68 years (range 62–76), diagnosed with Dupuytren’s contracture with palpable cord were enrolled in the study. 55.6% had relapsed after previous surgery. Injectable collagenase was administrated according to Product Information sheet into the metacarpophalangeal joints (66.7% of patients) or interphalangeal joints (33.3% of patients). Residual contracture <5º was achieved in 88.9% (n = 8) of patients. None experienced relapse. One was recently treated, so we have no efficacy results. Mild to moderate adverse events were reported in 88.9% of patients that resolved with appropriate treatment. These included peripheral oedema and hematoma (77.8%), skin lacerations at injection site (44.4%), paresthesia and pain (11.1%), scab, erythema or pruritus (33.3%). Average cost per patient for fasciectomy was 1,503 € and for treatment with collagenase was 923 €. Collagenase treatment cost an average 580 € (509.51–651.06 €, CI95%; p < 0.001) less per patient than fasciectomy. Conclusions Treatment for Dupuytren’s contracture with collagenase is effective and well tolerated in most of patients. It represents a decrease of 38.6% in costs to hospital versus the average cost of fasciectomy per patient. No conflict of interest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.